595 related articles for article (PubMed ID: 9322101)
1. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
Rizk B; Aboulghar M; Smitz J; Ron-El R
Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
[TBL] [Abstract][Full Text] [Related]
2. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C
Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
[TBL] [Abstract][Full Text] [Related]
3. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
[TBL] [Abstract][Full Text] [Related]
4. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome.
Aboulghar MA; Mansour RT; Serour GI; El Helw BA; Shaarawy M
Eur J Obstet Gynecol Reprod Biol; 1999 Nov; 87(1):81-5. PubMed ID: 10579621
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome.
McClure N; Healy DL; Rogers PA; Sullivan J; Beaton L; Haning RV; Connolly DT; Robertson DM
Lancet; 1994 Jul; 344(8917):235-6. PubMed ID: 7913160
[TBL] [Abstract][Full Text] [Related]
8. Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome: dopamine targets their common pathways.
Chen SU; Chou CH; Lin CW; Lee H; Wu JC; Lu HF; Chen CD; Yang YS
Hum Reprod; 2010 Mar; 25(3):757-67. PubMed ID: 20008399
[TBL] [Abstract][Full Text] [Related]
9. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.
van de Lagemaat R; Raafs BC; van Koppen C; Timmers CM; Mulders SM; Hanssen RG
Endocrinology; 2011 Nov; 152(11):4350-7. PubMed ID: 21896671
[TBL] [Abstract][Full Text] [Related]
10. The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome.
Albert C; Garrido N; Mercader A; Rao CV; Remohí J; Simón C; Pellicer A
Mol Hum Reprod; 2002 May; 8(5):409-18. PubMed ID: 11994537
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome.
Abramov Y; Barak V; Nisman B; Schenker JG
Fertil Steril; 1997 Feb; 67(2):261-5. PubMed ID: 9022600
[TBL] [Abstract][Full Text] [Related]
12. Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome.
Ludwig M; Bauer O; Lopens A; Jelkmann W; Diedrich K
Hum Reprod; 1998 Jan; 13(1):30-2. PubMed ID: 9512224
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of ovarian hyperstimulation syndrome--views and ideas.
Elchalal U; Schenker JG
Hum Reprod; 1997 Jun; 12(6):1129-37. PubMed ID: 9221989
[TBL] [Abstract][Full Text] [Related]
14. New insights in mechanisms for development of ovarian hyperstimulation syndrome.
Kasum M
Coll Antropol; 2010 Sep; 34(3):1139-43. PubMed ID: 20977119
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade.
Gómez R; Simón C; Remohí J; Pellicer A
Endocrinology; 2002 Nov; 143(11):4339-48. PubMed ID: 12399430
[TBL] [Abstract][Full Text] [Related]
16. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
[TBL] [Abstract][Full Text] [Related]
17. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model.
Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS
J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396
[TBL] [Abstract][Full Text] [Related]
18. Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats.
Gómez R; Lima I; Simón C; Pellicer A
Reproduction; 2004 Apr; 127(4):483-9. PubMed ID: 15047939
[TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries.
Agrawal R; Conway G; Sladkevicius P; Tan SL; Engmann L; Payne N; Bekir J; Campbell S; Jacobs H
Fertil Steril; 1998 Oct; 70(4):651-8. PubMed ID: 9797093
[TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome.
Chen CD; Wu MY; Chen HF; Chen SU; Ho HN; Yang YS
Fertil Steril; 1999 Aug; 72(2):286-92. PubMed ID: 10438997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]